Full Breakdown
AMA Launches Independent Vaccine Review Amid Federal Changes
2/11/2026, 6:59:21 AM
Overview of the AMA's Initiative
The American Medical Association (AMA) has initiated an independent review process to assess vaccine safety and efficacy for the upcoming respiratory viral season, signaling a departure from the current federal vaccine recommendations. This initiative is in collaboration with the Vaccine Integrity Project at the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota. The review will focus on vaccines for influenza, COVID-19, and respiratory syncytial virus (RSV). Michael Osterholm, director of CIDRAP, emphasized the need for vaccine decisions to be based on facts rather than political influences, stating, “Respiratory viruses hospitalize and kill tens of thousands of Americans every year.”
Context of Federal Vaccine Recommendations
The AMA's announcement comes in response to significant changes made by the Centers for Disease Control and Prevention (CDC) under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr. Following a reconstitution of the Advisory Committee on Immunization Practices (ACIP), the panel has delayed or ceased recommendations for several childhood vaccines, including the hepatitis B vaccine and the measles, mumps, rubella, and chickenpox vaccines. The AMA has criticized this shift, declaring that the ACIP's system has "effectively collapsed."
Declining Trust in Federal Health Agencies
Public trust in the CDC has significantly declined, with a recent KFF poll indicating that only 47% of Americans now express confidence in the agency, a stark drop from 85% in March 2020. This erosion of trust has prompted major medical organizations, including the AMA and the American Academy of Pediatrics, to take independent actions regarding vaccine recommendations, filling the void left by the federal government.
Details of the Evidence-Based Review Process
The AMA and the Vaccine Integrity Project's review process will include structured discussions to define key policy questions, ongoing expert panels, systematic literature reviews, and data transparency measures. AMA Trustee Sandra Adamson Fryhofer stated, “It is our duty as healthcare professionals to work across medicine, science, and public health to ensure the U.S. has a transparent, evidence-based process for vaccine recommendations.” The review will also disclose any relevant conflicts of interest and will be funded independently through philanthropy.
Official Responses and Criticism
In response to the AMA's initiative, HHS spokesperson Andrew Nixon refuted claims regarding the collapse of ACIP's process, asserting that it remains the nation's advisory body for vaccine recommendations based on "gold standard science." Nixon further stated, “While outside organizations continue to conduct their own analyses and confuse the American people, those efforts do not replace or supersede the federal process that continues to guide vaccine policy in the United States.”
Conclusion
The AMA's independent review of vaccine safety and efficacy highlights a growing divide between major medical organizations and federal health authorities. As the landscape of vaccine recommendations evolves, the implications for public health and trust in health agencies remain significant.
